<SEC-DOCUMENT>0001179110-21-008134.txt : 20210811
<SEC-HEADER>0001179110-21-008134.hdr.sgml : 20210811
<ACCEPTANCE-DATETIME>20210811183415
ACCESSION NUMBER:		0001179110-21-008134
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20210810
FILED AS OF DATE:		20210811
DATE AS OF CHANGE:		20210811

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Munch Mark
		CENTRAL INDEX KEY:			0001544635

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30833
		FILM NUMBER:		211164971

	MAIL ADDRESS:	
		STREET 1:		BRUKER CORPORATION
		STREET 2:		40 MANNING ROAD
		CITY:			BILLERICA
		STATE:			MA
		ZIP:			01821

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BRUKER CORP
		CENTRAL INDEX KEY:			0001109354
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				043110160
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		40 MANNING RD
		CITY:			BILLERICA
		STATE:			MA
		ZIP:			01821
		BUSINESS PHONE:		978663-3660

	MAIL ADDRESS:	
		STREET 1:		40 MANNING RD
		CITY:			BILLERICA
		STATE:			MA
		ZIP:			01821

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BRUKER BIOSCIENCES CORP
		DATE OF NAME CHANGE:	20030721

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BRUKER DALTONICS INC
		DATE OF NAME CHANGE:	20000315
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>edgar.xml
<DESCRIPTION>FORM 4 -
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0306</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2021-08-10</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001109354</issuerCik>
        <issuerName>BRUKER CORP</issuerName>
        <issuerTradingSymbol>BRKR</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001544635</rptOwnerCik>
            <rptOwnerName>Munch Mark</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>BRUKER CORPORATION</rptOwnerStreet1>
            <rptOwnerStreet2>40 MANNING ROAD</rptOwnerStreet2>
            <rptOwnerCity>BILLERICA</rptOwnerCity>
            <rptOwnerState>MA</rptOwnerState>
            <rptOwnerZipCode>01821</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Exec VP&amp;Pres Bruker Nano Inc.</officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2021-08-10</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>F</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>2989</value>
                    <footnoteId id="F1"/>
                </transactionShares>
                <transactionPricePerShare>
                    <value>82.61</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>85064</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <derivativeTable></derivativeTable>

    <footnotes>
        <footnote id="F1">Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/Sara Hussain, Attorney-in-Fact</signatureName>
        <signatureDate>2021-08-11</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>ex24munch.txt
<TEXT>
                                   EXHIBIT 24

                               POWER OF ATTORNEY

      KNOW  ALL  BY  THESE PRESENTS, that the undersigned hereby constitutes and
appoints each of Sara Hussain, Michael Simone, and Michael Rich, signing singly,
as his/her true and lawful attorney-in-fact to:

      (1)   execute  for  and on behalf of the undersigned, in the undersigned's
            capacity  as a director of Bruker Corporation (the "Company"), Forms
            3,  4,  and  5  in  accordance  with Section 16(a) of the Securities
            Exchange Act of 1934 and the rules thereunder and any other forms or
            reports  the  undersigned may be required to file in connection with
            the   undersigned's   ownership,   acquisition,  or  disposition  of
            securities of the Company;

      (2)   do and perform any and all acts for and on behalf of the undersigned
            which may be necessary or desirable to complete and execute any such
            Form  3, 4, or 5, or other form or report, and timely file such form
            or  report  with the U.S. Securities and Exchange Commission and any
            stock exchange or similar authority; and

      (3)   take  any other action of any type whatsoever in connection with the
            foregoing  which, in the opinion of such attorney-in-fact, may be of
            benefit  to,  in  the  best interest of, or legally required by, the
            undersigned, it being understood that the documents executed by such
            attorney-in-fact  on  behalf  of  the  undersigned, pursuant to this
            Power  of  Attorney,  shall  be  in such form and shall contain such
            terms  and conditions as such attorney-in-fact may approve in his or
            her discretion.

      The undersigned hereby grants to each such attorney-in-fact full power and
authority  to  do and perform each and every act and thing whatsoever requisite,
necessary, and proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could  do  if personally present, with full power of substitution or revocation,
hereby  ratifying  and  confirming all that such attorney-in-fact, or his or her
substitute  or  substitutes,  shall lawfully do or cause to be done by virtue of
this Power of Attorney and the rights and powers herein granted. The undersigned
acknowledges  that  no such attorney-in-fact, in serving in such capacity at the
request  of  the  undersigned,  is  hereby  assuming  any  of  the undersigned's
responsibilities  to  comply  with  Section  13 and Section 16 of the Securities
Exchange Act of 1934 and the rules thereunder, as amended.

      This Power of Attorney shall remain in full force and effect until revoked
by   the   undersigned   in   a   signed  writing  delivered  to  the  foregoing
attorneys-in-fact.

      IN  WITNESS  WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 30th day of September 2020.

/s/Mark Munch
-----------------------------------------
September 30, 2020
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
